According to ACR recommendations, allopurinol is strongly encouraged as a first-line urate-lowering medication. Genetic tests is recommended (for a variant identified as HLA B*5801) just before beginning allopurinol as the carriers of the gene are at an increased hazard of a extreme allergic response.As a support to our visitors, Harvard Well being